| abstract |
[PROBLEMS] To provide a new evaluation system capable of efficiently screening a therapeutic agent for stress urinary incontinence and an excellent therapeutic agent for stress urinary incontinence. A prophylactic / therapeutic agent for stress urinary incontinence comprising a substance that activates serotonin 5-HT 2C receptor, and prevention / treatment of stress urinary incontinence comprising a substance that stimulates an androgen binding site. A therapeutic and urinary incontinence preventive / therapeutic drug characterized by increasing the abdominal pressure by electrically stimulating the abdominal muscles of animals or the nerves that control them, and measuring the leak point pressure at this time A screening method is provided. [Selection figure] None |